Technical Analysis for MTPH - Midatech Pharma Plc

Grade Last Price % Change Price Change
F 27.65 0.55% 0.15
MTPH closed up 0.55 percent on Friday, May 14, 2021, on 29 percent of normal volume.
Earnings due: May 17
*** please verify all earnings dates ***

Trend Table & Recent EOD Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Down Down Down
Historical MTPH trend table...

Date Alert Name Type % Chg
180 Bearish Setup Bearish Swing Setup 0.00%
Narrow Range Bar Range Contraction 0.00%
Calm After Storm Range Contraction 0.55%
Doji - Bullish? Reversal 0.55%
Calm After Storm Range Contraction 0.55%
Narrow Range Bar Range Contraction 0.55%
Outside Day Range Expansion 0.55%
Hammer Candlestick Bullish 1.58%
Calm After Storm Range Contraction 1.58%
Narrow Range Bar Range Contraction 1.58%
Older End-of-Day Signals for MTPH ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.


Midatech Pharma Plc Description

Midatech Pharma PLC is an early-stage biopharmaceutical company that focuses on commercializing and developing products in oncology and other therapeutic areas. The Company's segments include Pipeline Research and Development, and Commercial. The Pipeline Research and Development segment seeks to develop products using the nanomedicine and sustained release technology platforms. The Commercial segment distributes and sells the commercial products. Its products include Zuplenz, Gelclair, Oravig and Soltamox. Zuplenz is an oral soluble film indicated for moderately emetogenic chemotherapy-induced nausea and vomiting (CINV), radiotherapy-induced nausea and vomiting (RINV), and post-operative nausea and vomiting (PONV). Gelclair is a product indicated for the management and relief of pain due to oral mucositis. Oravig is an orally dissolving buccal tablet approved for oral thrush. Soltamox is an oral liquid solution of tamoxifen citrate for the prevention of breast cancer.


Sector: Healthcare
Industry: Biotechnology
Keywords: Pharmaceutical Pain Medicine Pipe Earl Radio Cancer Medical Specialties Oncology Therapy Clinical Medicine Prevention Biopharmaceutical Technology Platforms Radiotherapy Breast Cancer Chemotherapy Nanomedicine Cancer Treatments Gelclair

Is MTPH a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 87.0
52 Week Low 15.0
Average Volume 88,007
200-Day Moving Average 30.80
50-Day Moving Average 29.97
20-Day Moving Average 28.11
10-Day Moving Average 27.94
Average True Range 1.62
ADX 17.61
+DI 19.61
-DI 26.18
Chandelier Exit (Long, 3 ATRs ) 27.13
Chandelier Exit (Short, 3 ATRs ) 30.87
Upper Bollinger Band 30.13
Lower Bollinger Band 26.10
Percent B (%b) 0.39
BandWidth 14.35
MACD Line -0.75
MACD Signal Line -0.82
MACD Histogram 0.0683
Fundamentals Value
Market Cap 17.44 Million
Num Shares 63.1 Million
EPS -4.40
Price-to-Earnings (P/E) Ratio -6.28
Price-to-Sales 20.66
Price-to-Book 3.68
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.84
Resistance 3 (R3) 27.86 27.82 27.81
Resistance 2 (R2) 27.82 27.77 27.81 27.80
Resistance 1 (R1) 27.73 27.74 27.71 27.71 27.79
Pivot Point 27.69 27.69 27.68 27.68 27.69
Support 1 (S1) 27.61 27.64 27.59 27.59 27.51
Support 2 (S2) 27.57 27.61 27.56 27.50
Support 3 (S3) 27.48 27.57 27.49
Support 4 (S4) 27.46